Regeneron 'Kickbacks' Fueled Blockbuster Profits, Suit Says
Insurance company Humana Inc. has accused Regeneron of inflating the cost of its vision loss drug Eylea by operating a purported scheme to make charitable donations to offset the price that...To view the full article, register now.
Already a subscriber? Click here to view full article